RTO Stock Recent News

Rentokil Initial plc (NYSE:RTO ) Q1 2025 Trading Update Call April 17, 2025 4:00 AM ET Company Participants Andy Ransom - CEO Paul Edgecliffe-Johnson - CFO Conference Call Participants Suhasini Varanasi - Goldman Sachs Annelies Vermeulen - Morgan Stanley James Beard - Deutsche Bank Andy Grobler - BNP Paribas Nicole Manion - UBS Operator Good morning, ladies and gentlemen, and welcome to our conference call for Rentokil Initial's First Quarter Trading Update. Let me hand it over to CEO, Andy Ransom.

Rentokil Initial PLC (LSE:RTO) said its North American business had a soft start to the year, with organic revenue growth of just 0.7% in the first quarter. The pest control group blamed weak lead generation and lower contract sales, particularly across its residential and commercial segments.

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Toronto, Ontario--(Newsfile Corp. - April 16, 2025) - Libra Lithium Corp. ("Libra") is pleased to announce the acceptance of the 2024 Bernie Schnieders Discovery of the Year Award for its spodumene discovery at its Soules Bay-Caron Project in Ontario, Canada ("SBC" or the "Project"). Presented annually by the Northwestern Ontario Prospectors Association ("NWOPA"), this prestigious honour celebrates ground breaking discoveries made in Northwestern Ontario during the previous calendar year.

MEMPHIS, Tenn. , April 14, 2025 /PRNewswire/ -- Terminix®, a Rentokil Terminix company, announced today its annual list of the Top 50 Most Mosquito-Infested Cities in the U.S. based on 2024 service data from more than 300 branches nationwide.

VANCOUVER, BC / ACCESS Newswire / March 31, 2025 / Verisante Technology, Inc. (TSXV:VER.H) ("Verisante") announces that on March 28, 2025, it mutually agreed with SunRegen Healthcare AG ("SunRegen") to terminate the Letter of Intent ("LOI") dated August 12, 2024, to acquire SunRegen Healthcare AG ("SunRegen"), by way of a Reverse Takeover ("RTO"). Verisante's common shares were previously halted from trading in connection with a proposed RTO with SunRegen Healthcare AG.

Annual Report and Annual General Meeting CRAWLEY, GB / ACCESS Newswire / March 26, 2025 / In compliance with Listing Rule 6.4.1, the Company announces that the following documents, in unedited full text, have today been filed with the Financial Conduct Authority and are available for inspection via the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism: Annual Report and Financial Statements for the year ended 31 December 2024 (the Annual Report 2024); Notice of 2025 Annual General Meeting (AGM); and Proxy Form for the 2025 AGM. The documents will be posted today, and the Annual Report 2024 and the Notice of 2025 AGM have been published on the Company's website at rentokil-initial.com/investors.

The pest control industry is attractive due to its capital-light, non-cyclical nature, providing relatively predictable revenue streams. This feature is being enhanced through greater sales through subscriptions and long-term contracts. Meanwhile, the industry benefits from a growth tailwind due to greater urbanisation, a regulatory push on commercial customers, and global warming potentially increasing insect populations. Rentokil's stock has declined over 50% from its peak price. We believe this is attributed primarily from challenges in integrating the Terminix acquisition. We believe this is a fixable problem.

Rentokil Initial plc (NYSE:RTO ) Q4 2024 Earnings Conference Call March 6, 2025 4:15 AM ET Company Participants Andrew Ransom - Chief Executive Officer Paul Edgecliffe-Johnson - Chief Financial Officer Conference Call Participants Simona Sarli - Bank of America Annelies Vermeulen - Morgan Stanley Suhasini Varanasi - Goldman Sachs Group, Inc. Christopher Bamberry - Peel Hunt LLP Sylvia Barker - JPMorgan Chase & Co. James Beard - Deutsche Bank AG Ollie Davies - Redburn Atlantic Allen Wells - Jefferies James Rosenthal - Barclays Bank Andrew Grobler - BNP Paribas Exane Nicole Manion - UBS Andrew Ransom Good morning, everyone. So here's a quick look at today's agenda.

Rentokil Initial PLC gave investors little to cheer about on Thursday with largely expected news that profit tumbled last year on challenges within its North American. Shares dropped 4.4% in the wake of the update, which showed statutory pre-tax profit down 17.9% at £405 million.

Rentokil Initial PLC has firmed up a drop in profit after a “challenging” year on struggles within its North American business. Statutory pre-tax profit dropped 17.9% to £405 million in the year to December 31, as revenue climbed 1.1% to £5.44 billion, the pest-control business said on Thursday.